Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.61 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.61 |
| ▸ | NPC1 | O15118 | 2/20 | 0.61 |
| ▸ | MAOA | P21397 | 2/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.61 |
| ▸ | S100A4 | P26447 | 2/20 | 0.61 |
| ▸ | APAF1 | O14727 | 2/20 | 0.61 |
| ▸ | TDP2 | O95551 | 2/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.61 |
| ▸ | CES2 | O00748 | 1/20 | 0.61 |
| ▸ | TERT | O14746 | 1/20 | 0.61 |
| ▸ | PLIN1 | O60240 | 1/20 | 0.61 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.61 |
| ▸ | LMNA | P02545 | 1/20 | 0.61 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.61 |
| ▸ | BCHE | P06276 | 1/20 | 0.61 |
| ▸ | POLB | P06746 | 1/20 | 0.61 |
| ▸ | PTPRC | P08575 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29543474 | 1.00 | MEN1 (0.61) | MEN1KMT2AMAPK1NPC1MAOA | |
| SCHEMBL29437946 | 1.00 | MEN1 (0.61) | MEN1KMT2AMAPK1NPC1MAOA | |
| SCHEMBL28694051 | 1.00 | MEN1 (0.61) | MEN1KMT2AMAPK1NPC1MAOA | |
| SCHEMBL28904690 | 1.00 | MEN1 (0.61) | MEN1KMT2AMAPK1NPC1MAOA | |
| SCHEMBL4368339 | 1.00 | MEN1 (0.61) | MEN1KMT2AMAPK1NPC1MAOA | |
| SCHEMBL58152 | 1.00 | MEN1 (0.61) | MEN1KMT2AMAPK1NPC1MAOA | |
| SCHEMBL29711875 | 1.00 | MEN1 (0.61) | MEN1KMT2AMAPK1NPC1MAOA | |
| SCHEMBL29067593 | 1.00 | MEN1 (0.61) | MEN1KMT2AMAPK1NPC1MAOA | |
| SCHEMBL49870 | 1.00 | MEN1 (0.61) | MEN1KMT2AMAPK1NPC1MAOA | |
| SCHEMBL11875421 | 1.00 | MEN1 (0.61) | MEN1KMT2AMAPK1NPC1MAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 361 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119978007-A | Condensed cyclic compound and organic light-emitting device comprising the same | 三星显示有限公司 | 2025-05-13 | — | — | CN | claimed |
| CN-119768014-A | Heterocyclic compound, organic light-emitting device, and electronic device | 三星显示有限公司 | 2025-04-04 | — | — | CN | claimed |
| CN-113717057-B | Amine compound and organic light emitting device including the same | 三星显示有限公司 | 2025-04-01 | — | — | CN | claimed |
| CN-111293234-B | Organic light emitting device and electronic apparatus | 三星显示有限公司 | 2025-02-21 | — | — | CN | claimed |
| CN-111384300-B | Organic light emitting device and apparatus including the same | 三星电子株式会社 | 2025-01-17 | — | — | CN | claimed |
| CN-112838172-B | Organic light emitting device | 三星显示有限公司 | 2024-08-09 | — | — | CN | claimed |
| CN-118201453-A | Amine-based compound, light-emitting device, electronic apparatus, and electronic device | 三星显示有限公司 | 2024-06-14 | — | — | CN | claimed |
| CN-109400486-B | Amine compound and organic light emitting device including the same | 三星显示有限公司 | 2023-10-13 | — | — | CN | claimed |
| CN-109560214-B | organic light emitting device | 三星显示有限公司 | 2023-08-29 | — | — | CN | claimed |
| CN-111740024-B | organic light emitting device | 三星显示有限公司 | 2023-08-25 | — | — | CN | claimed |
| US-20040029861-A1 | Use of pyridyl alkane, pyridyl alkene and/or pyridyl alkine acid amides in the treatment of tumors or for immunosuppression | KLINGE PHARMA GMBH | 2004-02-12 | — | — | US | claimed |
| US-20040009967-A1 | Pyridyl alkene- and pyridyl alkine- acid amides as cytostatics and immuno-suppressives | KLINGE PHARMA GMBH | 2004-01-15 | — | — | US | claimed |
| US-20030162972-A1 | Pyridyl alkane acid amides as cytostatics and immunosupressives | KLINGE PHARMA GMBH | 2003-08-28 | — | — | US | claimed |
| JP-2000512652-A | — | — | 2000-09-26 | — | — | JP | claimed |
| EP-0934309-A1 | NEW PYRIDYL ALKANE ACID AMIDES AS CYTOSTATICS AND IMMUNOSUPPRESSIVES | Klinge Pharma GmbH (DE) | 1999-08-11 | — | — | EP | claimed |
| EP-0923570-A1 | PYRIDYL ALKENE- AND PYRIDYL ALKINE- ACID AMIDES AS CYTOSTATICS AND IMMUNOSUPPRESSIVES | Klinge Pharma GmbH (DE) | 1999-06-23 | — | — | EP | claimed |
| EP-0912176-A1 | USE OF PYRIDYL ALKANE, PYRIDYL ALKENE AND/OR PYRIDYL ALKINE ACID AMIDES IN THE TREATMENT OF TUMORS OR FOR IMMUNOSUPPRESSION | Klinge Pharma GmbH (DE) | 1999-05-06 | — | — | EP | claimed |
| WO-1997048696-A1 | PYRIDYL ALKENE- AND PYRIDYL ALKINE- ACID AMIDES AS CYTOSTATICS AND IMMUNOSUPPRESSIVES | KLINGE PHARMA GMBH (DE) | 1997-12-24 | — | — | WO | claimed |
| WO-1997048397-A1 | USE OF PYRIDYL ALKANE, PYRIDYL ALKENE AND/OR PYRIDYL ALKINE ACID AMIDES IN THE TREATMENT OF TUMORS OR FOR IMMUNOSUPPRESSION | KLINGE PHARMA GMBH (DE) | 1997-12-24 | — | — | WO | claimed |
| WO-1997048695-A1 | NEW PYRIDYL ALKANE ACID AMIDES AS CYTOSTATICS AND IMMUNOSUPPRESSIVES | KLINGE PHARMA GMBH (DE) | 1997-12-24 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040009967-A1 | Pyridyl alkene- and pyridyl alkine- acid amides as cytostatics and immuno-suppressives | IDO1, ALK, ARG1 | MEN1 2138/4885KMT2A 1694/4885MAPK1 1160/4885 |
| US-20040029861-A1 | Use of pyridyl alkane, pyridyl alkene and/or pyridyl alkine acid amides in the treatment of tumors or for immunosuppression | ALK, IDO1, PDXK | MEN1 866/4885KMT2A 1493/4885MAPK1 549/4885 |
| US-20030162972-A1 | Pyridyl alkane acid amides as cytostatics and immunosupressives | ALK, TYMP, ANXA1 | MEN1 1667/4885KMT2A 1559/4885MAPK1 462/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.